Smoking Cessation Interventions for Quitting Smoking
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people of color who smoke quit by testing different ways to connect them with support services. It will compare two approaches: Longitudinal Proactive Outreach (LPO), which offers regular follow-ups and tailored support calls, and Ask-Advice-Connect (AAC), which provides enhanced regular care. The trial focuses on individuals who have smoked at least once in the last month and are part of the Hennepin Healthcare or MCHS system. Participants should be able to communicate in English or Spanish and have their contact information listed in their health records.
As an unphased trial, this study offers a unique opportunity to contribute to innovative approaches that may improve smoking cessation support for diverse communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that the Ask-Advice-Connect (AAC) approach is generally safe and well-tolerated. Studies have found it effectively helps smokers connect with treatment services, such as quitlines and nicotine replacement therapy, without major safety concerns. This method primarily involves advising smokers to quit and linking them to resources, which is considered low-risk.
Similarly, Longitudinal Proactive Outreach (LPO) safely increases participation in smoking cessation programs. Research indicates that LPO can successfully reach smokers who might not seek help independently. This approach includes regular follow-ups to encourage quitting, without significant negative effects.
Both AAC and LPO support people who want to quit smoking, and both have been studied in various settings with no major safety issues.12345Why are researchers excited about this trial?
Researchers are excited about these smoking cessation interventions because they offer a new approach by combining Ask-Advice-Connect (AAC) with Longitudinal Proactive Outreach (LPO). Unlike standard care, which often relies on brief counseling and nicotine replacement therapy, the AAC + LPO approach provides ongoing, personalized support through motivational interviewing calls at key intervals—baseline, 3, 6, and 9 months post-enrollment. This ongoing support aims to keep participants engaged and motivated to quit smoking over the long term, potentially increasing success rates compared to traditional methods.
What evidence suggests that this trial's treatments could be effective for smoking cessation among BIPOC populations?
Research has shown that the Ask-Advice-Connect (AAC) approach, which participants in this trial may receive, can significantly increase enrollment in smoking cessation programs. One study found that direct connection to the Quitline resulted in enrollment rates 13 times higher than traditional methods. Additionally, about 16.6% of participants reported quitting smoking after six months.
The Longitudinal Proactive Outreach (LPO), another treatment option in this trial, has also helped more people quit smoking, particularly those who are hard to reach. This proactive approach has been linked to higher quit rates among individuals from various economic backgrounds and has effectively encouraged smokers from disadvantaged groups to use cessation treatments. These findings suggest that both AAC and LPO could be promising methods to help people stop smoking.34678Who Is on the Research Team?
Steven Fu, MD, MSCE
Principal Investigator
Minneapolis Veterans Affairs Medical Center
Are You a Good Fit for This Trial?
This trial is for BIPOC individuals who are part of the Hennepin Healthcare or MCHS system, speak English or Spanish, currently smoke cigarettes, and want to quit. They must have contact information in their health record. People with cognitive impairments or under legal guardianship, or those who've opted out of research can't participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive AAC plus an MI tailored outreach call at baseline and at 3, 6, and 9 months post-enrollment, with enhanced access to State Quitline and Nicotine Replacement Therapy
Follow-up
Participants are monitored for smoking abstinence and quality of life changes
What Are the Treatments Tested in This Trial?
Interventions
- Ask-Advice-Connect (AAC)
- Longitudinal Proactive Outreach (LPO)
Ask-Advice-Connect (AAC) is already approved in United States for the following indications:
- Tobacco cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor